---
title: "Weekly Recap | Vital Farms -8.94%, consensus target above spot"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300855440.md"
description: "Vital Farms (VITL) fell 8.94% this week to close at $9.06, underperforming the S&P 500, which slipped 0.27%, by roughly 8.67 percentage points. The stock opened Monday at $9.84 and briefly touched $9.93 before selling off. It broke below $9 on Tuesday, hit an intraday low of $8.685 on Friday, then recovered slightly into the close. Weekly amplitude came to 12.65%."
datetime: "2026-10-03T08:41:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300855440.md)
  - [en](https://longbridge.com/en/news/300855440.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300855440.md)
generator: "portal-rs"
---

# Weekly Recap | Vital Farms -8.94%, consensus target above spot

## The Week

Vital Farms (VITL) fell 8.94% this week to close at $9.06, underperforming the S&P 500, which slipped 0.27%, by roughly 8.67 percentage points. The stock opened Monday at $9.84 and briefly touched $9.93 before selling off. It broke below $9 on Tuesday, hit an intraday low of $8.685 on Friday, then recovered slightly into the close. Weekly amplitude came to 12.65%.

## Key Events

News this week clustered around two themes. On Tuesday, 29 September, two reports placed VITL within a broader consumer staples reshuffle: one mapped sector-wide growth anxiety through drone deals and store wars, another flagged organic food names hitting fresh highs. The most specific item arrived on Saturday, 3 October, when a short-interest report named Vital Farms alongside Beyond Meat as among the most heavily shorted consumer staples stocks below $2 billion in market cap. The company had no standalone earnings or regulatory event during the week.

## Analyst Ratings

Among 10 institutions covering Vital Farms, 3 rate it buy, 1 overweight, and 6 hold, with no underweight or sell ratings. The consensus rating is buy, with a consensus target of $13.2222, about 45.94% above the current price of $9.06. Target prices range from $10.00 to $18.00, a wide spread that suggests meaningful disagreement. Within the packaged food and meat industry, the stock sits 16th out of 54 names.

## The Week Ahead

The US macro calendar picks up next week. Monday, 5 October brings the S&P Global services PMI final (prior 58.7) and ISM non-manufacturing PMI (prior 55.4, estimate 55). Tuesday, 6 October sees international trade data and the goods trade balance, followed by EIA crude and Cushing inventories on Wednesday, 7 October. No company-specific earnings are scheduled, so the main event is how consumer staples respond to macro prints.

## In Short

The tension this week is between valuation and positioning. The consensus target sits roughly 46% above spot, and most brokers rate the stock buy or overweight, but the latest session’s large-lot flow turned net seller. At the same time, VITL ranks among the most heavily shorted small-cap consumer staples names, with the share price near the low end of its 60-session range. The question now is whether a lower price triggers short covering, and how macro data next week filters into consumer sector sentiment.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [VITL.US](https://longbridge.com/en/quote/VITL.US.md)

## Related News & Research

- [Vital Farms soars on report it's reviewing strategic alternatives, including a sale](https://longbridge.com/en/news/299238546.md)
- [VITL: Expanded farm network and pricing strategy drive growth, with 2026 revenue guided to $775–800M](https://longbridge.com/en/news/298950729.md)
- [Warren Buffett's Successor, Greg Abel, Just Went Shopping in the Tech Sector Again!](https://longbridge.com/en/news/302535520.md)
- [Rocket Lab Just Had Another Setback. Here’s Why I’m Finally Buying the Stock Anyway](https://longbridge.com/en/news/302545565.md)
- [Nokia Q3 profit rises 95% to EUR 156 million](https://longbridge.com/en/news/302649426.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**